Annexin IV is Differentially Expressed in Clear Cell Carcinoma of the Ovary
Authors:
- Bin CaiBCBin Cai
- Ling LiuLLLing Liu
- Yixia YangYYYixia Yang
- Xiaoping WanXWXiaoping Wan
- 1 December 2009
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 19 (9) , 1545-1549
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Molecular Diagnosis of Burkitt's LymphomaNew England Journal of Medicine, 2006
- Microarray Analysis and Tumor ClassificationNew England Journal of Medicine, 2006
- Clinical and molecular differences between clear cell and papillary serous ovarian carcinomaJournal of Surgical Oncology, 2006
- Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profilingOncogene, 2005
- Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancerInternational Journal of Gynecological Cancer, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Clinical characteristics of clear cell carcinoma of the ovaryCancer, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Clinical Characteristics of Clear Cell Carcinoma of the OvaryGynecologic Oncology, 1998